Julien Adam
Inserm(FR)Inserm(FR)Université Paris-Saclay(FR)Institut Gustave Roussy(FR)Universiti Malaysia Sarawak(MY)Hôpital Marie Lannelongue(FR)Hôpital Paris Saint-Joseph(FR)RWTH Aachen University(DE)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations, Occupational and environmental lung diseases, Cancer Research and Treatments, Cancer Genomics and Diagnostics
Most-Cited Works
- → B cells are associated with survival and immunotherapy response in sarcoma(2020)1,848 cited
- → Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy(2014)1,012 cited
- → Association of the Lung Immune Prognostic Index With Immune Checkpoint Inhibitor Outcomes in Patients With Advanced Non–Small Cell Lung Cancer(2018)934 cited
- → Hyperprogressive Disease in Patients With Advanced Non–Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent Chemotherapy(2018)725 cited
- → CD8+CD103+ Tumor–Infiltrating Lymphocytes Are Tumor-Specific Tissue-Resident Memory T Cells and a Prognostic Factor for Survival in Lung Cancer Patients(2015)589 cited
- → Exosomes released by chronic lymphocytic leukemia cells induce the transition of stromal cells into cancer-associated fibroblasts(2015)